You are on page 1of 1

A CLINICAL TRIAL FOR

PATIENTS WITH SKIN


CANCER.

Moderna is creating individualized, mRNA-based


personalized cancer vaccines (PCVs) to deliver a
custom-tailored medicine for one patient at a
time. This study is for people with high risk
melanoma (skin cancer), who have had surgery
for their skin cancer and are currently disease-
free, but who have a high risk of it coming back.

VOLUNTEERS NEEDED
Recent Melanoma study? A
study for those with a high risk
of it coming back is looking for
volunteers. See if you may
qualify.

You might also like